BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3094149)

  • 1. Clinical implications of monoclonal light chains.
    Solomon A
    Semin Oncol; 1986 Sep; 13(3):341-9. PubMed ID: 3094149
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple myeloma with serum IgM kappa and Bence Jones lambda biclonal gammopathy.
    Graziani MS; Lippi U
    Clin Chem; 1986 Dec; 32(12):2220-1. PubMed ID: 3096615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign Bence Jones gammopathy.
    Paladini G; Sala PG; Santini PA
    Acta Haematol; 1980; 63(5):241-6. PubMed ID: 6774550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria in multiple myeloma and related diseases.
    Ganeval D; Lacour B; Chopin N; Grünfeld JP
    Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
    Solomon A; Frangione B; Franklin EC
    J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases.
    Colls BM; Lorier MA
    N Z Med J; 1975 Oct; 82(549):221-6. PubMed ID: 1059967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.
    Isobe T; Osserman EF
    N Engl J Med; 1974 Feb; 290(9):473-7. PubMed ID: 4204196
    [No Abstract]   [Full Text] [Related]  

  • 9. Bence-Jones proteins and light chains of immunoglobulins (second of two parts).
    Solomon A
    N Engl J Med; 1976 Jan; 294(2):91-8. PubMed ID: 53788
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunofluorescent studies of the myeloma kidney with special reference to light chain disease.
    Levi DF; Williams RC; Lindstrom FD
    Am J Med; 1968 Jun; 44(6):922-33. PubMed ID: 4172911
    [No Abstract]   [Full Text] [Related]  

  • 11. [Multiple myeloma].
    Pascali E; Pezzoli A; Feruglio FS
    Recenti Prog Med; 1985 Apr; 76(4):225-40. PubMed ID: 3898254
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of Urinary Free Light Chain Testing for Monitoring of Bence Jones Proteinuria.
    Delgado JC
    J Appl Lab Med; 2019 May; 3(6):1059-1060. PubMed ID: 31639698
    [No Abstract]   [Full Text] [Related]  

  • 13. Light chain disease and massive proteinuria.
    Lessard F; Bannon P; Lepage R; Joly JG
    Clin Chem; 1985 Mar; 31(3):475-7. PubMed ID: 3918811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bence Jones proteinuria and myeloma kidney.
    Chauveau D; Choukroun G
    Nephrol Dial Transplant; 1996 Mar; 11(3):413-5. PubMed ID: 8671805
    [No Abstract]   [Full Text] [Related]  

  • 15. Double Bence Jones proteinuria.
    Kanoh T; Yago K
    Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the frequency of kappa and lambda light chains in 347 sera containing a monoclonal IgG, IgA, IgD, or Bence-Jones protein.
    Fine JM
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):199-202. PubMed ID: 4192027
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney involvement in multiple myeloma and related disorders.
    Ganeval D; Cathomen M; Noël LH; Grünfeld JP
    Contrib Nephrol; 1982; 33():210-22. PubMed ID: 6811198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary amyloidosis and thrombophlebitis as complications of Bence-Jones plasmacytoma (lambda type)].
    Baier J; Neumann H; Grossmann R; Ricken D
    Med Klin (Munich); 1991 Jan; 86(1):53-7. PubMed ID: 1901936
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
    Sanchez de cos Escuin J; Moreno Norueira J; Carneado de la Fuente J
    Rev Clin Esp; 1978 Sep; 150(6):345-9. PubMed ID: 103147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.